Taiwan will end its mandatory COVID-19 quarantine for arrivals from October 13 and welcome tourists back, the government said on Thursday, completing a major step on its plan to re-open to the outside world. Taiwan had kept some of its entry and quarantine rules in place as large parts of the rest of Asia relaxed… Read More Taiwan to scrap mandatory coronavirus quarantine for arrivals from October 13
German Chancellor Olaf Scholz has tested positive for coronavirus and is showing mild symptoms of a cold, a government spokesperson said on Monday. Scholz is isolating in the federal chancellery. He has cancelled all his public appearances this week but will attend scheduled meetings remotely, said an emailed statement. Germany is rolling out booster vaccinations… Read More German Chancellor Olaf Scholz tests positive for coronavirus
Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. “I’m feeling well and symptom free,” Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid. Paxlovid is an antiviral medication that is… Read More Pfizer CEO Albert Bourla tests positive for coronavirus
Queen Margrethe of Denmark has tested positive for COVID-19 for the second time this year, the royal court said on Wednesday. The 82-year-old head of state, who has been on the throne for half a century, has cancelled her appointments for the week. She attended the Queen Elizabeth’s funeral in London on Monday. Queen Margrethe,… Read More Denmark’s Queen Margrethe tests positive for coronavirus
China’s CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country’s drug regulator for emergency use as a booster, potentially benefiting its business. The inhaled version of Cansino’s adenovirus-vectored COVID-19 vaccine has obtained the green light from the National Medical Products Administration, the company said in a… Read More China approves CanSino’s inhaled coronavirus vaccine for emergency use
The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a broad fall vaccination campaign that could begin within days. The new vaccines also include the original version of the virus targeted by all… Read More U.S. FDA approves coronavirus vaccines engineered for Omicron variant
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech U.S.-listed shares were down about 1.5% and Moderna shares slipped 1.7%… Read More Moderna files lawsuit against Pfizer/BioNTech for patent infringement over coronavirus vaccine
Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine retooled to target the Omicron variant. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant BA.4/BA.5 variants of the virus along with the original coronavirus strain. It is intended… Read More Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant
247NEWSUPDATE BLOG 